Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Shares of medical devices company AngioDynamics, Inc. (ANGO) are rising more than 10% Thursday morning on better-than-expected second-quarter results.


RTTNews | Jan 7, 2021 10:32AM EST

10:31 Thursday, January 7, 2021 (RTTNews.com) - Shares of medical devices company AngioDynamics, Inc. (ANGO) are rising more than 10% Thursday morning on better-than-expected second-quarter results.

The company reported a net loss of $4.3 million, or $0.11 per share in the second quarter compared with net loss of $2.7 million, or $0.07 per share, a year ago.

On an adjusted basis, earnings of $0.01 per share in the quarter beat the average estimate of analysts polled by Thomson Reuters for a loss of $0.02 per share.

Net sales for the second quarter increased 4% year-over-year to $72.8 million. The consensus estimate was for $67.35 million.

"In the second half of the year, we expect ongoing COVID-related headwinds as well as typical third-quarter seasonality, which is contemplated in our full-year guidance. We are excited about the planned launch of our multi-purpose mechanical aspiration thrombectomy device in calendar 2021," said Jim Clemmer, President and Chief Executive Officer of AngioDynamics, Inc.

ANGO, currently at $17.94, touched a new high of $19.52 this morning.

Read the original article on RTTNews ( https://www.rttnews.com/3158604/stock-alert-angiodynamics-rising-on-upbeat-quarterly-results.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC